Document is current
Any future updates will be listed below
-
Authors
Wang, Guangchuan https://orcid.org/0000-0001-5315-1599
Chow, Ryan D. https://orcid.org/0000-0002-1872-6307
Bai, Zhigang https://orcid.org/0000-0001-9234-9354
Zhu, Lvyun
Errami, Youssef
Dai, Xiaoyun
Dong, Matthew B.
Ye, Lupeng https://orcid.org/0000-0003-3901-6598
Zhang, Xiaoya
Renauer, Paul A.
Park, Jonathan J. https://orcid.org/0000-0001-5887-3953
Shen, Li
Ye, Hanghui
Fuchs, Charles S.
Chen, Sidi https://orcid.org/0000-0002-3819-5005
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP2CA238295, R33CA225498, U54CA209992-8697)
U.S. Department of Health & Human Services | NIH | Center for Information Technology (R01CA231112)
- License Information
-
More Information
Article History
Received: 1 July 2019
Accepted: 20 August 2019
First Online: 14 October 2019
Competing interests
: A patent application has been filed by Yale University related to data in the present study. C.S.F. serves a consulting role for Agios, Bain Capital, Bayer, Celgene, Dicerna, Five Prime Therapeutics, Gilead Sciences, Eli Lilly, Entrinsic Health, Genentech, KEW, Merck, Merrimack Pharmaceuticals, Pfizer, Roche, Sanofi, Taiho and Unum Therapeutics, and also serves as a director for CytomX Therapeutics and owns unexercised stock options for CytomX and Entrinsic Health.
